THE SUM OF TUMOR SIZE PREDICTS THE EFFICACY OF IMMUNE CHECKPOINT INHIBITORS IN NON-SMALL CELL LUNG CANCER

被引：0
作者：
Shiraishi, Yusuke [1 ]
Marumo, Satoshi [1 ]
Amimoto, Hisanori [1 ]
Yamaki, Haruka [1 ]
Shirata, Masahiro [1 ]
Imoto, Takamitsu [1 ]
Kitajima, Takamasa [1 ]
Inoue, Daiki [1 ]
Katayama, Yuko [1 ]
Fukui, Motonari [1 ]
机构：
[1] Kitano Hosp, Tazuke Kofukai Med Res Inst, Resp Dis Ctr, Osaka, Japan
来源：
RESPIROLOGY | 2018年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
AP547
引用
收藏
页码：289 / 289
页数：1
相关论文
共 50 条
[31]   Identification of gene signatures relevant to the efficacy of immune checkpoint inhibitors in non-small cell lung cancer [J].
Liu, Min ;
Li, Qiao ;
Meng, Xiaohong ;
Cui, Yanan ;
Sun, Weirong ;
Wang, Hongmei ;
Gao, Qingjun .
MEDICINE, 2024, 103 (49) :e40569
[32]   The efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer harboring driver mutations [J].
Sakamoto, Hiroaki ;
Tanaka, Hisashi ;
Shiratori, Toshihiro ;
Baba, Keisuke ;
Ishioka, Yoshiko ;
Itoga, Masamichi ;
Taima, Kageaki ;
Hasegawa, Yukihiro ;
Takanashi, Shingo ;
Tasaka, Sadatomo .
MOLECULAR AND CLINICAL ONCOLOGY, 2019, 10 (06) :610-614
[33]   Efficacy of Immune Checkpoint Inhibitors in KRAS-Mutant Non-Small Cell Lung Cancer (NSCLC) [J].
Jeanson, Arnaud ;
Tomasini, Pascale ;
Souquet-Bressand, Maxime ;
Brandone, Nicolas ;
Boucekine, Mohamed ;
Grangeon, Mathieu ;
Chaleat, Solene ;
Khobta, Natalyia ;
Milia, Julie ;
Mhanna, Laurent ;
Greillier, Laurent ;
Biemar, Julie ;
Nanni, Isabelle ;
Ouafik, L'houcine ;
Garcia, Stephane ;
Mazieres, Julien ;
Barlesi, Fabrice ;
Mascaux, Celine .
JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (06) :1095-1101
[34]   Efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer harboring BRAF mutations [J].
Wang, Haowei ;
Cheng, Lei ;
Zhao, Chao ;
Zhou, Fei ;
Jiang, Tao ;
Guo, Haoyue ;
Shi, Jinpeng ;
Chen, Peixin ;
Tang, Zhuoran ;
Mao, Shiqi ;
Jia, Keyi ;
Ye, Lingyun ;
Cai, Chenlei ;
Li, Xuefei ;
Chen, Xiaoxia ;
Zhou, Caicun .
TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (02) :219-+
[35]   Efficacy and Prognostic Factors of Immune Checkpoint Inhibitors in the Treatment of Advanced Non-small Cell Lung Cancer [J].
Hu, Yu-xiong ;
Guo, Li-jing ;
Lin, Meng-qing ;
Lin, Qing-yu .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2023, 46 (04) :161-166
[36]   The effect of tumor mutation burden on immune checkpoint inhibitors in non-small cell lung cancer. [J].
Zhao, Jie ;
Dong, Yiting ;
Bai, Hua ;
Duan, Jianchun ;
Wang, Guoqiang ;
Xu, Jiachen ;
Wang, Zhijie ;
Wang, Jie .
CANCER RESEARCH, 2021, 81 (13)
[37]   Coexistence of Emphysema With Non-small-cell Lung Cancer Predicts the Therapeutic Efficacy of Immune Checkpoint Inhibitors [J].
Takayama, Yusuke ;
Nakamura, Takashi ;
Fukushiro, Yuki ;
Mishima, Shohei ;
Masuda, Ken ;
Shoda, Hiroyasu .
IN VIVO, 2021, 35 (01) :467-474
[38]   The Relationship of Diabetes Mellitus to Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer [J].
Jacobi, Oded ;
Landman, Yosef ;
Reinhorn, Daniel ;
Icht, Oded ;
Sternschuss, Michal ;
Rotem, Ofer ;
Finkel, Inbar ;
Allen, Aaron M. ;
Dudnik, Elizabeth ;
Goldstein, Daniel A. ;
Zer, Alona .
ONCOLOGY, 2021, 99 (09) :555-561
[39]   Immunologic constant of rejection as a predictive biomarker of immune checkpoint inhibitors efficacy in non-small cell lung cancer [J].
Alice Mogenet ;
Pascal Finetti ;
Emilie Denicolai ;
Laurent Greillier ;
Pascaline Boudou-Rouquette ;
François Goldwasser ;
Gwenael Lumet ;
Michele Ceccarelli ;
Daniel Birnbaum ;
Davide Bedognetti ;
Emilie Mamessier ;
Fabrice Barlesi ;
François Bertucci ;
Pascale Tomasini .
Journal of Translational Medicine, 21
[40]   The efficacy of immune checkpoint inhibitors in anaplastic lymphoma kinase-positive non-small cell lung cancer [J].
Heo, Ja Yoon ;
Park, Changhee ;
Keam, Bhumsuk ;
Ock, Chan-Young ;
Kim, Miso ;
Kim, Tae Min ;
Kim, Dong-Wan ;
Kim, Se Hyun ;
Kim, Yu Jung ;
Lee, Jong Seok ;
Heo, Dae Seog .
THORACIC CANCER, 2019, 10 (11) :2117-2123
12345